They're asking for a September meeting... Could take a few months before they actually meet and only if FDA grants them one... The Aspire rep thought BTD had a significant chance back in late June??? I'm sure they filed for BTD status around that time... If not, someone needs to explain who tipped off Aspire for their comments? Or, was that a ploy to sell shares?
Think for a while. Galera already had BTD before B data got finalised. If B had turned out to be clearly inferior to GC4419 then what that might have done to IPIX's changes of getting BTD out of FDA. Improved hugely, or gotten worse?
I am not saying that IPIX did wait for Galera divulging more details. I am saying that to me that makes sense. I feel that is more than can be said about most other scenarios bouncing around here. Usually posters and abstracts are available on-line a week or two before a conferences begin. IPIX would had had time to peruse Galera's presentation, be less than impressed and decide that it is worth trying for BTD.
News 
Market Data 
Discover 
AI
